Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal lidocaine 10% versus 5% for headache relief after head trauma
IRCT20181103041539N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine in post-traumatic headache (PTH) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Headache severity over time and Patient satisfaction with treatment. Started Nov 2018; status: completed.
02
Drugs
lidocaine
03
Conditions
post-traumatic headache (PTH)
Beyond the preview
Go deeper on IRCT20181103041539N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181103041539N1.